Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
INIPARIB
Not Marketed
Breast Cancer
TCD11608NANCT01173497Summary
INIPARIB
Not Marketed
Uterine Carcinosarcoma
TCD11615NANCT00687687Summary
INIPARIB
Not Marketed
Malignant Glioma
TCD11616NANCT00687765Summary
INIPARIB
Not Marketed
Advanced solid tumors
TED11451NANCT01213381Summary
INIPARIB
Not Marketed
Neoplasm malignant
TED11746NANCT01455532Summary
INSULIN ASPART
Insulin aspart Sanofi
Diabetes Mellitus, Type 1 and 2
EFC15081GEMELLI 1NCT03211858Tabulated ResultsSummary - 6 monthsSummary - 1 year
INSULIN ASPART
Insulin aspart Sanofi
Diabetes Mellitus, Type 1 and 2
EFC15082NAEudraCT Number: 2017-000092-84Tabulated Results
INSULIN ASPART
Not marketed
Diabetes Mellitus, Type 1
EFC15178GEMELLI XNCT03874715Tabulated Results
INSULIN ASPART
Insulin aspart Sanofi
Diabetes Mellitus, Type 1
PDY12695NANCT03202875Publication's Reference
INSULIN ASPART
Insulin aspart Sanofi
Diabetes Mellitus, Type 1 and 2
PDY15083NANCT03436498Publication's Reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted